Obesity 2016: Minimally Invasive Bariatric Devices Gaining Steam

With no end in sight for the obesity epidemic, there is a vast and underserved market opportunity for manufacturers developing minimally invasive solutions for obesity that can fill the treatment gap between invasive bariatric surgery and conservative weight loss methods (diet, exercise, and drugs). Despite some high-profile setbacks in the last few years, the market for minimally invasive bariatric devices is gaining steam as several companies have recently launched obesity devices on the US market while others have completed clinical trials and are advancing toward US regulatory approval.

Overweight

With over two-thirds of US adults, equivalent to more than 136 million people, defined as overweight or obese (BMI >25 kg/m2), there is no end in sight for the obesity epidemic. Bariatric surgery remains the gold standard for treating patients with morbid obesity (BMI >40 kg/m2), but this is costly, irreversible and only 1% to 2% of the eligible patient population are willing or able to undergo these procedures. In 2015 alone, roughly 19 million US adults qualified as morbidly obese, and yet surgeons only performed an estimated 196,000 bariatric surgeries, including laparoscopic sleeve gastrectomies, gastric bypass surgeries, and laparoscopic adjustable bands according to recent estimates by the American Society for Metabolic and Bariatric Surgery (ASMBS). (See Figures 1 and 2.)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Gastroenterology

More from Device Area